Impaired ACE2 glycosylation and protease activity lowers COVID‐19 susceptibility in Gitelman's and Bartter's syndromes

Detalles Bibliográficos
Autores principales: Bertoldi, Giovanni, Ravarotto, Verdiana, Sgarabotto, Luca, Davis, Paul A., Gobbi, Laura, Calò, Lorenzo A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414342/
https://www.ncbi.nlm.nih.gov/pubmed/34875124
http://dx.doi.org/10.1111/joim.13426
_version_ 1784775963938127872
author Bertoldi, Giovanni
Ravarotto, Verdiana
Sgarabotto, Luca
Davis, Paul A.
Gobbi, Laura
Calò, Lorenzo A.
author_facet Bertoldi, Giovanni
Ravarotto, Verdiana
Sgarabotto, Luca
Davis, Paul A.
Gobbi, Laura
Calò, Lorenzo A.
author_sort Bertoldi, Giovanni
collection PubMed
description
format Online
Article
Text
id pubmed-9414342
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-94143422022-08-31 Impaired ACE2 glycosylation and protease activity lowers COVID‐19 susceptibility in Gitelman's and Bartter's syndromes Bertoldi, Giovanni Ravarotto, Verdiana Sgarabotto, Luca Davis, Paul A. Gobbi, Laura Calò, Lorenzo A. J Intern Med Research Letters John Wiley and Sons Inc. 2021-12-16 2022-04 /pmc/articles/PMC9414342/ /pubmed/34875124 http://dx.doi.org/10.1111/joim.13426 Text en © 2021 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Letters
Bertoldi, Giovanni
Ravarotto, Verdiana
Sgarabotto, Luca
Davis, Paul A.
Gobbi, Laura
Calò, Lorenzo A.
Impaired ACE2 glycosylation and protease activity lowers COVID‐19 susceptibility in Gitelman's and Bartter's syndromes
title Impaired ACE2 glycosylation and protease activity lowers COVID‐19 susceptibility in Gitelman's and Bartter's syndromes
title_full Impaired ACE2 glycosylation and protease activity lowers COVID‐19 susceptibility in Gitelman's and Bartter's syndromes
title_fullStr Impaired ACE2 glycosylation and protease activity lowers COVID‐19 susceptibility in Gitelman's and Bartter's syndromes
title_full_unstemmed Impaired ACE2 glycosylation and protease activity lowers COVID‐19 susceptibility in Gitelman's and Bartter's syndromes
title_short Impaired ACE2 glycosylation and protease activity lowers COVID‐19 susceptibility in Gitelman's and Bartter's syndromes
title_sort impaired ace2 glycosylation and protease activity lowers covid‐19 susceptibility in gitelman's and bartter's syndromes
topic Research Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414342/
https://www.ncbi.nlm.nih.gov/pubmed/34875124
http://dx.doi.org/10.1111/joim.13426
work_keys_str_mv AT bertoldigiovanni impairedace2glycosylationandproteaseactivitylowerscovid19susceptibilityingitelmansandbartterssyndromes
AT ravarottoverdiana impairedace2glycosylationandproteaseactivitylowerscovid19susceptibilityingitelmansandbartterssyndromes
AT sgarabottoluca impairedace2glycosylationandproteaseactivitylowerscovid19susceptibilityingitelmansandbartterssyndromes
AT davispaula impairedace2glycosylationandproteaseactivitylowerscovid19susceptibilityingitelmansandbartterssyndromes
AT gobbilaura impairedace2glycosylationandproteaseactivitylowerscovid19susceptibilityingitelmansandbartterssyndromes
AT calolorenzoa impairedace2glycosylationandproteaseactivitylowerscovid19susceptibilityingitelmansandbartterssyndromes

Ejemplares similares